In a major shift for women’s health, the U.S. Food and Drug Administration (FDA) has begun removing the long-standing “black-box” warnings from many menopausal hormone-therapy products. These warnings — which appeared in bold, black borders at the top of medication labels — were the strongest caution the FDA could require and influenced how both patients … Continue reading FDA Updates Hormone Therapy Warnings: What This Means for Women’s Health